Drug for the treatment of the central nervous system

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/220

A61K 31/52 (2006.01)

Patent

CA 1121726

M-3 APPLICATION FOR LETTERS PATENT DRUG FOR THE TREATMENT OF THE CENTRAL NERVOUS SYSTEM ABSTRACT OF THE DISCLOSURE THE PRESENT APPLICATION RELATES TO COMPOSITIONS WHICH INFLUENCE THE CENTRAL NERVOUS SYSTEM AND WHICH ARE ESPECIALLY USEFUL IN THE TREATMENT OF HYPERKINESIS AND RIGIDITY. THESE COMPOSITIONS CONTAIN AS ACTIVE INGREDIENT 1,3-DIMETIIYL-5-AMINO- ADAMANTANE IN THE FORM OF THE FREE BASE OR A PHARMACEUTICALLY- ACCEPTABLE SALT THEREOF, TOGETHER WITH A METHYLXANTHINE COMPOUND, E.G., CAFFEINE OR THEOPHYLLINE, IN AN AMOUNT UP TO ABOUT FIFTEEN MILLIGRAMS OF THE METHYLXANTHINE COMPOUND PER EACH MILLIGRAM OF THE 1,3-DIMETHYL-5-AMINOADAMANTANE COMPOUND. THESE COMPOSITIONS ARE USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, PARTICULARLY OF PARKINSON'S DISEASE, DEPRESSIONS, SPASTICITY, RIGIDITY, HYPERKINESIS, AND THE LIKE. THE COMPOSITIONS POSSESS UNPREDICTABLE BENEFICIAL PROPERTIES OF A SYNERGISTIC NATURE. THE APPLICATION ALSO RELATES TO THE TREATMENT OF SUCH CENTRAL NERVOUS SYSTEM AILMENTS OR CONDITIONS WITH A COMBINATION OF THE SAID TWO ACTIVE AGENTS EITHER CONCURRENTLY OR TOGETHER IN THE SAME DOSAGE FORM OR UNIT.

342584

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Drug for the treatment of the central nervous system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug for the treatment of the central nervous system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug for the treatment of the central nervous system will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-821742

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.